🩺 GLP-1s boost outcomes after bariatric surgery
A real-world study found that starting GLP-1s improved mortality in obesity patients who had metabolic bariatric surgery. This research, led by Guy Loic Nguefang, compared three groups of adults with obesity. Postoperative initiation lowered all-cause mortality by 88% versus surgery alone, while preoperative initiation showed an 80% reduction. Postoperative timing also linked to better cardiovascular safety and fewer complications like small bowel obstruction. Overall, the study suggests postoperative initiation offers the best balance for survival and safety. 🩺